{"eu_number": "EU-1-13-846", "parse_date": "2022-11-23 17:10:10.118872", "decisions": [{"filename": "EU-1-13-846_h_a_dec_0.pdf", "eu_aut_date": "2013-06-21 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": true, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_1.pdf", "eu_aut_date": "2014-11-28 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_10.pdf", "eu_aut_date": "2021-04-02 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_11.pdf", "eu_aut_date": "2021-04-30 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_12.pdf", "eu_aut_date": "2021-06-17 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_2.pdf", "eu_aut_date": "2015-05-27 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_3.pdf", "eu_aut_date": "2015-06-22 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_4.pdf", "eu_aut_date": "2015-08-28 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_5.pdf", "eu_aut_date": "2015-11-27 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_6.pdf", "eu_aut_date": "2016-12-12 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_7.pdf", "eu_aut_date": "2017-09-21 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_8.pdf", "eu_aut_date": "2018-08-02 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-13-846_h_a_dec_9.pdf", "eu_aut_date": "2018-10-23 00:00:00", "eu_brand_name_initial": "Xtandi", "active_substance": "enzalutamide", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "Astellas Pharma Europe B.V.", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}], "annexes": [{"pdf_file": "EU-1-13-846_h_a_anx_0.pdf", "xml_file": "EU-1-13-846_h_a_anx_0.xml", "is_initial": true, "creation_date": "D:20130520144524+02'00'", "modification_date": "D:20130520144557+02'00'", "initial_type_of_eu_authorization": "standard", "eu_type_of_medicine": "small molecule", "therapeutic_indications": "xtandi is indicated for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.\n"}, {"pdf_file": "EU-1-13-846_h_a_anx_1.pdf", "xml_file": "EU-1-13-846_h_a_anx_1.xml", "is_initial": false, "creation_date": "D:20141117004400+01'00'", "modification_date": "D:20141117012934+01'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_10.pdf", "xml_file": "EU-1-13-846_h_a_anx_10.xml", "is_initial": false, "creation_date": "D:20191211103154+01'00'", "modification_date": "D:20191217094156+01'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_11.pdf", "xml_file": "EU-1-13-846_h_a_anx_11.xml", "is_initial": false, "creation_date": "D:20191211103154+01'00'", "modification_date": "D:20191217094156+01'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_12.pdf", "xml_file": "EU-1-13-846_h_a_anx_12.xml", "is_initial": false, "creation_date": "D:20210514163318+02'00'", "modification_date": "D:20210514164034+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_13.pdf", "xml_file": "EU-1-13-846_h_a_anx_13.xml", "is_initial": false, "creation_date": "D:20210514163318+02'00'", "modification_date": "D:20210514164034+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_2.pdf", "xml_file": "EU-1-13-846_h_a_anx_2.xml", "is_initial": false, "creation_date": "D:20150420215515+02'00'", "modification_date": "D:20150421110948+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_3.pdf", "xml_file": "EU-1-13-846_h_a_anx_3.xml", "is_initial": false, "creation_date": "D:20150611135718+02'00'", "modification_date": "D:20150612080405+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_4.pdf", "xml_file": "EU-1-13-846_h_a_anx_4.xml", "is_initial": false, "creation_date": "D:20150701125933+01'00'", "modification_date": "D:20150701125933+01'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_5.pdf", "xml_file": "EU-1-13-846_h_a_anx_5.xml", "is_initial": false, "creation_date": "D:20151016104908+02'00'", "modification_date": "D:20151019121135+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_6.pdf", "xml_file": "EU-1-13-846_h_a_anx_6.xml", "is_initial": false, "creation_date": "D:20160425151145+02'00'", "modification_date": "D:20160426120403+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_7.pdf", "xml_file": "EU-1-13-846_h_a_anx_7.xml", "is_initial": false, "creation_date": "D:20170814160849+02'00'", "modification_date": "D:20170814163158+02'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_8.pdf", "xml_file": "EU-1-13-846_h_a_anx_8.xml", "is_initial": false, "creation_date": "D:20180109131206+01'00'", "modification_date": "D:20180109133721+01'00'"}, {"pdf_file": "EU-1-13-846_h_a_anx_9.pdf", "xml_file": "EU-1-13-846_h_a_anx_9.xml", "is_initial": false, "creation_date": "D:20181017152508+02'00'", "modification_date": "D:20181017153134+02'00'"}], "epars": [{"filename": "EU-1-13-846_h_a_public-assessment-report", "ema_procedure_start_initial": "26/06/2012", "chmp_opinion_date": "25/04/2013", "eu_legal_basis": ["article 8.3"], "eu_prime_initial": "NA", "ema_rapp": "arantxa sancho-lopez", "ema_corapp": "bengt ljungberg", "ema_reexamination": "no", "eu_accel_assess_g": "yes"}], "omars": []}